Platelet Concentrate in Achilles Tendon Repair
Study Details
Study Description
Brief Summary
People operated for a rupture of the Achilles tendon receive a concentrate of their own platelets injected into the operated area. The study is randomized and single-blinded, with 20 treated patients and 20 controls, who get no injection. The primary endpoint is a mechanical property of the tendon after 12 weeks (modulus of elasticity), as measured by a special type of radiography. This radiography uses 0.8 mm metal markers, which are injected into the tendon. The tendon is mechanically loaded during radiography and its strain can be measured as increased distance between the markers. Other mechanical variables at 6, 12 and 52 weeks are secondary variables, as well as a validated patient-administrated questionaire at 1 year.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1 Injection of autologous platelet concentrate into repair site |
Biological: Autologous platelets
Local injection 10mL, about 2.5 x 10E10 platelets.
|
Placebo Comparator: 2 No injection |
Biological: no injection
|
Outcome Measures
Primary Outcome Measures
- Modulus of elasticity [12 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Achilles tendon rupture, age 18-65.
Exclusion Criteria:
- Any counterindication for surgical treatment.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ Hosp | Linköping | Sweden | Se 88185 |
Sponsors and Collaborators
- University Hospital, Linkoeping
Investigators
- Principal Investigator: per aspenberg, University of Linköping
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Trombocytakilles